Literature DB >> 20201659

Acute eosinophilic myocarditis: diagnosis and treatment.

Houman Rezaizadeh1, Monica Sanchez-Ross, Edo Kaluski, Marc Klapholz, Bunyad Haider, Christine Gerula.   

Abstract

Hypereosinophilic syndrome (HES) is a rare disorder of unregulated eosinophilia, which if untreated, may lead to systemic tissue infiltration and inflammation. Cardiac involvement is a common and serious associated complication. We describe a case of HES associated myocarditis mimicking a non-ST elevation MI (NSTEMI). Unlike myocarditis in general, our patient responded well to high dose methylprednisone, the standard of care in HES. We review the clinical presentation, pathophysiology, pathology and treatment of eosinophilic myocarditis related to HES.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201659     DOI: 10.3109/17482940903578998

Source DB:  PubMed          Journal:  Acute Card Care        ISSN: 1748-2941


  14 in total

1.  Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration.

Authors:  SuFey Ong; Davinna L Ligons; Jobert G Barin; Lei Wu; Monica V Talor; Nicola Diny; Jillian A Fontes; Elizabeth Gebremariam; David A Kass; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2015-01-23       Impact factor: 4.307

2.  Loeffler Endocarditis in Idiopathic Hypereosinophilic Syndrome Demonstrated by Magnetic Resonance Imaging Effectively Treated by Corticosteroids.

Authors:  You Zhou; Dong Huang; Junbo Ge
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

3.  IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function.

Authors:  Eric D Abston; Jobert G Barin; Daniela Cihakova; Adriana Bucek; Michael J Coronado; Jessica E Brandt; Djahida Bedja; Joseph B Kim; Dimitrios Georgakopoulos; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Circ Heart Fail       Date:  2012-03-27       Impact factor: 8.790

4.  Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; SuFey Ong; DeLisa Fairweather; Djahida Bedja; Natalie R Stickel; Jillian A Fontes; Ashley B Cardamone; Dongfeng Zheng; Kathleen L Gabrielson; Noel R Rose; Daniela Ciháková
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

Review 5.  Eosinophilic Myocarditis: Clinical Case and Literature Review.

Authors:  Paulo Dinis; Rogério Teixeira; Luís Puga; Carolina Lourenço; Maria Carmo Cachulo; Lino Gonçalves
Journal:  Arq Bras Cardiol       Date:  2018-06       Impact factor: 2.000

6.  Eosinophilic myocarditis in Churg-Strauss disease: Case report

Authors:  Martín Barmak; Cristhian E Scatularo; Andrea Giraldo; Alejandro Pellegrini
Journal:  Arch Cardiol Mex       Date:  2022-01-03

7.  Hypereosinophilic syndrome presenting as acute ischemic stroke, myocardial infarction, and arterial involvement: A case report.

Authors:  Ran-Ran Sun; Tuan-Zhi Chen; Min Meng
Journal:  World J Clin Cases       Date:  2022-04-16       Impact factor: 1.337

8.  Eosinophilic myocarditis.

Authors:  U Baandrup
Journal:  Herz       Date:  2012-12       Impact factor: 1.740

9.  Eosinophilic myocarditis: two case reports and review of the literature.

Authors:  Jacques Rizkallah; Angela Desautels; Amrit Malik; Shelley Zieroth; Davinder Jassal; Farrukh Hussain; Francisco Cordova
Journal:  BMC Res Notes       Date:  2013-12-17

10.  Eosinophilic Myocarditis due to Toxocariasis: Not a Rare Cause.

Authors:  Shunichi Shibazaki; Shunsuke Eguchi; Takashi Endo; Tadamasa Wakabayashi; Makoto Araki; Yoshiaki Gu; Taku Imai; Kouji Asano; Norihide Taniuchi
Journal:  Case Rep Cardiol       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.